Technology | 2024.12.21
Penn Medicine developing next generation of viral vectors for genome editing - PhillyVoice.com
| PhillyVoice.com | Penn Medicine developing next generation of viral vectors for genome editing PhillyVoice.com In May, Penn announced a gene therapy alliance with Biogen, the oldest biotechnology company in the United States, aimed at advancing gene therapy research and gene editing technologies. The collaboration, potentially worth up to $2 billion for the ... |
For more information, please visit
http://news.google.com/news/url?sa=t&fd=[...]g-next-generation-viral-vector
